Difficulty: Medium
Average Score: 75%
Practice
This fibric acid derivative increases blood levels of high density lipoproteins (HDL):
Correct answer
C
Rationale
In this question, the correct answer is C) Gemfibrozil (Lopid). Gemfibrozil is a fibric acid derivative that works by increasing the levels of high-density lipoproteins (HDL) in the blood. HDL is considered the "good" cholesterol as it helps remove LDL (low-density lipoproteins) or "bad" cholesterol from the bloodstream, reducing the risk of cardiovascular diseases.
Option A) Cholestyramine (Questran) is a bile acid sequestrant that works by binding to bile acids in the intestine, leading to increased excretion of cholesterol. It does not increase HDL levels.
Option B) Lovastatin (Mevacor) is a statin medication that works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis. Statins primarily lower LDL cholesterol levels and have a modest effect on increasing HDL levels.
Option D) Probucol (Lorelco) is a cholesterol-lowering medication that mainly works by decreasing LDL levels and has minimal impact on raising HDL levels.
Educationally, understanding the mechanism of action of different lipid-lowering medications is crucial for healthcare professionals to make informed decisions when managing patients with dyslipidemia. Knowing which medications target specific lipid profiles, such as increasing HDL levels, helps in individualizing treatment regimens for better patient outcomes.
Option A) Cholestyramine (Questran) is a bile acid sequestrant that works by binding to bile acids in the intestine, leading to increased excretion of cholesterol. It does not increase HDL levels.
Option B) Lovastatin (Mevacor) is a statin medication that works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis. Statins primarily lower LDL cholesterol levels and have a modest effect on increasing HDL levels.
Option D) Probucol (Lorelco) is a cholesterol-lowering medication that mainly works by decreasing LDL levels and has minimal impact on raising HDL levels.
Educationally, understanding the mechanism of action of different lipid-lowering medications is crucial for healthcare professionals to make informed decisions when managing patients with dyslipidemia. Knowing which medications target specific lipid profiles, such as increasing HDL levels, helps in individualizing treatment regimens for better patient outcomes.